Examkin

Question

Difficulty: MediumPharmacologic Interventions

A 62-year-old woman presents to the outpatient clinic with a 4-day history of intense vulvar pruritus, dysuria, and a thick, white, odorless vaginal discharge. Her medical history is significant for a mechanical mitral valve replacement 5 years ago, for which she takes daily warfarin. Her other medications include metoprolol and low-dose aspirin. Her last international normalized ratio (INR) obtained one week ago was 2.8, which is within her target range of 2.5 to 3.5. Vital signs are within normal limits. Pelvic examination reveals significant vulvovaginal erythema and thick, adherent white plaques on the vaginal walls. A potassium hydroxide (KOH) preparation of the vaginal discharge reveals branching pseudohyphae and budding yeast. Which of the following is the most appropriate pharmacologic intervention for this patient?

  1. Intravaginal clotrimazoleAnswer
  2. B
    Oral fluconazole
  3. C
    Oral metronidazole
  4. D
    Intravaginal clindamycin
  5. E
    Oral ketoconazole

Answer

Intravaginal clotrimazole is the best choice because it provides effective local treatment for candidiasis while avoiding a dangerous systemic interaction with warfarin.
The correct answer provides a targeted, highly effective antifungal treatment for vulvovaginal candidiasis while acting purely locally. Because the patient is anticoagulated with warfarin, avoiding systemic drug interactions is critical. Warfarin's active S-enantiomer is primarily metabolized by the hepatic cytochrome P450 2C9 (CYP2C9) enzyme. Intravaginal clotrimazole has minimal to no systemic absorption and will not interfere with CYP2C9 metabolism, ensuring the patient's INR remains stable within her target range.

Step-by-Step Solution

1
Diagnose the patient's acute presentation based on clinical and microscopic findings.
The patient has vulvovaginal candidiasis.
Intense vulvar pruritus, thick white discharge, and branching pseudohyphae with budding yeast on a KOH preparation are classic diagnostic features of a Candida infection.
2
Identify the standard first-line therapies for this condition.
Uncomplicated vulvovaginal candidiasis is typically treated with either oral fluconazole or a topical azole (e.g., intravaginal clotrimazole or miconazole).
Both modalities are highly effective and recommended by clinical guidelines for uncomplicated cases.
3
Evaluate the patient's current medication list for potential drug-drug interactions.
The patient is actively taking warfarin for a mechanical mitral valve replacement.
Prescribing systemic medications requires verifying safety against the patient's existing high-risk drug regimen.
4
Select the safest pharmacologic intervention that avoids adverse effects.
Intravaginal clotrimazole should be prescribed instead of oral fluconazole.
Oral fluconazole is a strong inhibitor of CYP2C9, the primary enzyme that metabolizes warfarin. Co-administration risks a supratherapeutic INR and fatal hemorrhage. Intravaginal clotrimazole acts locally with negligible systemic absorption, bypassing this interaction.

Key Concept

In patients taking warfarin, localized therapies (like intravaginal clotrimazole) should be prioritized over interacting systemic agents (like oral fluconazole) to treat superficial infections, thereby avoiding CYP2C9 inhibition and severe bleeding complications.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic